As demand for GLP-1 receptor agonists (GLP-1RAs) surges, fragmented prescribing practices threaten patient safety. A ...

Clinical trials that rely on subjective or semi-subjective endpoints, such as clinician-reported outcomes or patient-reported symptoms, face distinct challenges when it comes to data integrity.

At the beginning of the decade, the role of drug safety attracted unprecedented mainstream attention. That was as the ...

The rapid adoption of AI tools across the healthcare industry has vast potential to save both providers and payers time and ...

Genmab has named Matt Kiely as General Manager for the United Kingdom, marking a key step in its European commercial ...

Blue Cell Therapeutics, a biotech developing ‘off-the-shelf’ allogeneic stem cell therapies for diseases where angiogenesis ...

Flexo printing and Clear Code are two innovations that make MM Packaging stand out. Flexo printing creates 100% seamless ...

Post-marketing pharmacovigilance streamlined by automation ...

At Visions4Health, we believe successful market access starts with a clear-eyed understanding of what is really happening on ...

Of all the healthcare policies the government blasted out over the summer, one should have stood out for pharma. The NHS is edging towards one of the most radical reforms in its history: the creation ...

Despite bold ambitions in the Life Sciences Vision and NHS 10-Year Plan, uptake of new medicines remains slow. Can industry, ...

AI is already playing a fundamental role in every stage of the drug discovery process – from ideation all the way through to ...